DE3841767A1 - Neue tnf-peptide - Google Patents

Neue tnf-peptide

Info

Publication number
DE3841767A1
DE3841767A1 DE3841767A DE3841767A DE3841767A1 DE 3841767 A1 DE3841767 A1 DE 3841767A1 DE 3841767 A DE3841767 A DE 3841767A DE 3841767 A DE3841767 A DE 3841767A DE 3841767 A1 DE3841767 A1 DE 3841767A1
Authority
DE
Germany
Prior art keywords
ala
leu
val
gln
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE3841767A
Other languages
German (de)
English (en)
Inventor
Hans-Joachim Dr Boehm
Lothar Dr Daum
Andreas Dr Haupt
Bernhard Dr Schmied
Nigel Dr Walker
Johann-Christian Dr Zechel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to DE3841767A priority Critical patent/DE3841767A1/de
Priority to EP90900120A priority patent/EP0447432A1/fr
Priority to JP2500554A priority patent/JPH04502306A/ja
Priority to PCT/EP1989/001466 priority patent/WO1990006939A1/fr
Priority to CA002005052A priority patent/CA2005052A1/fr
Publication of DE3841767A1 publication Critical patent/DE3841767A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3841767A 1988-12-12 1988-12-12 Neue tnf-peptide Withdrawn DE3841767A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE3841767A DE3841767A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide
EP90900120A EP0447432A1 (fr) 1988-12-12 1989-12-02 Peptides tnf
JP2500554A JPH04502306A (ja) 1988-12-12 1989-12-02 新規ｔｎｆペプチド
PCT/EP1989/001466 WO1990006939A1 (fr) 1988-12-12 1989-12-02 Peptides tnf
CA002005052A CA2005052A1 (fr) 1988-12-12 1989-12-11 Peptides tnf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3841767A DE3841767A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide

Publications (1)

Publication Number Publication Date
DE3841767A1 true DE3841767A1 (de) 1990-06-13

Family

ID=6368962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3841767A Withdrawn DE3841767A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide

Country Status (5)

Country Link
EP (1) EP0447432A1 (fr)
JP (1) JPH04502306A (fr)
CA (1) CA2005052A1 (fr)
DE (1) DE3841767A1 (fr)
WO (1) WO1990006939A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341471A1 (de) * 1993-12-02 1995-06-08 Schering Ag Tumor-Nekrose-Faktor-alpha-inaktivierende CDR-Peptide
US7109291B2 (en) * 2001-05-22 2006-09-19 Gradient Compounds capable of modulating the activity and stimulating the production of a catalytic antibody

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001211A1 (fr) * 1991-07-05 1993-01-21 Peptide Technology Limited Peptide neutralisant la toxicite du facteur de necrose tumorale alpha (fnt) et/ou la toxicite des lipopolysaccharides (lps)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3211263A1 (de) * 1981-03-31 1983-01-27 Otsuka Pharmaceutical Co. Ltd., Tokyo Human-interferon verwandte peptide, antigene und antikoerper, sowie verfahren zu deren herstellung
EP0190127A1 (fr) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Agents polypeptides immunotherapeutiques
EP0205038A1 (fr) * 1985-05-29 1986-12-17 Suntory Limited Polypeptide, son procédé de préparation, micro-organisme et utilisation pharmaceutique

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341471A1 (de) * 1993-12-02 1995-06-08 Schering Ag Tumor-Nekrose-Faktor-alpha-inaktivierende CDR-Peptide
US7109291B2 (en) * 2001-05-22 2006-09-19 Gradient Compounds capable of modulating the activity and stimulating the production of a catalytic antibody

Also Published As

Publication number Publication date
CA2005052A1 (fr) 1990-06-12
JPH04502306A (ja) 1992-04-23
WO1990006939A1 (fr) 1990-06-28
EP0447432A1 (fr) 1991-09-25

Similar Documents

Publication Publication Date Title
DE69329425T2 (de) Dolastatin analog
DE69320339T2 (de) Derivate des Dolastatin
DE3841753A1 (de) Neue tnf-peptide
DE3841759A1 (de) Neue tnf-peptide
DE3841763A1 (de) Neue tnf-peptide
DE3841768A1 (de) Neue tnf-peptide
DE3939797A1 (de) Neue vom neuropeptid y abgeleitete peptide
DE69029377T2 (de) Substituierungsanaloge von magaininpeptiden
DE69012901T2 (de) Hämoregulierende Peptide.
DE3841761A1 (de) Neue tnf-peptide
DE3841767A1 (de) Neue tnf-peptide
DE3841762A1 (de) Neue tnf-peptide
DE3841764A1 (de) Neue tnf-peptide
DE3841755A1 (de) Neue tnf-peptide
DE3841754A1 (de) Neue tnf-peptide
DE4041188A1 (de) Neue tnf-peptide
DE4041187A1 (de) Neue tnf-peptide
EP0570375A1 (fr) Nouveaux peptides a activite anticoagulante.
DE4041189A1 (de) Neue-tnf-peptide
DE1668875A1 (de) Neue Peptide mit ACTH-Wirkung

Legal Events

Date Code Title Description
8130 Withdrawal